ArticleJournal of bone oncology2021

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE.

Daniele Santini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.